Home /Research /Radiation Protection and Occupational Exposure on <sup>68</sup>Ga-PSMA-11–Based Cerenkov Luminescence Imaging Procedures in Robot-Assisted Prostatectomy
SURGICAL

Radiation Protection and Occupational Exposure on <sup>68</sup>Ga-PSMA-11–Based Cerenkov Luminescence Imaging Procedures in Robot-Assisted Prostatectomy

Pedro Fragoso Costa, Wolfgang P. Fendler, Ken Herrmann, Patrick Sandach, Hong Grafe, Maarten Grootendorst, Lukas Püllen, Claudia Kesch, Ulrich Krafft, Jan Philipp Radtke, Stephan Tschirdewahn, Boris Hadaschik, Christopher Darr

Year
2021
Citations
8
Access
Open access

Abstract

<b>Introduction:</b> Cerenkov Luminescence Imaging (CLI) was successfully implemented in the intraoperative context as a form of cancer radio-guided surgery, showing promise in the detection of surgical margins during robot-assisted radical prostatectomy (RARP). The current study was designed to provide a quantitative description on the occupational radiation exposure to surgery and histopathology personnel from CLI-guided RARP after injection of [<sup>68</sup>Ga]Ga-PSMA-11 using a single injection PET/CT / CLI protocol. <b>Methods:</b> Ten patients with preoperative [<sup>68</sup>Ga]Ga-PSMA-11 administration and intraoperative CLI were included. Patient dose rate was measured, pre-PET/CT (<i>N</i> = 10) and post-PET/CT (<i>N</i> = 5) at one meter distance of four patient regions (A: head, B: right side, C: left side and D: feet). Electronic Personal Dosimeters (EPD) were used for intraoperative occupational exposure (<i>N</i> = 10). Measurements included the first surgical assistant and scrub nurse at the operating table and the CLI imager / surgeon at the robotic console, encompassing the whole duration of surgery and CLI image acquisition. An estimation of exposure to histopathology personnel was performed by measuring prostate specimens (<i>N</i> = 8) on a Germanium detector. <b>Results:</b> The pre-PET/CT measured dose rate values averaged (± SD) 5.3 ± 0.9 µSv/h. This corresponds to a patient-specific dose rate constant for positions B and C of 0.047 µSv/h*MBq. Post PET/CT dose rate values averaged (± SD) 1.04 ± 1.00 µSv/h. The patient-specific dose rate constant values were 0.011 µSv/h*MBq, 0.026 µSv/h*MBq, 0.024 µSv/h*MBq and 0.003 µSv/h*MBq, corresponding to regions A-D. EPD readings revealed an average (±SD) personal equivalent dose of 9.0 ± 7.1, 3.3 ± 3.9, 0.7 ± 0.7 µSv for first surgical assistant, scrub nurse and CLI imager / surgeon, respectively. The median (Interquartile range - IQR) Germanium detector measured activity of the prostate specimen was 2.96 kBq (2.23; 7.65 kBq). <b>Conclusion:</b> Single injection of [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT / CLI procedures are associated with a reasonable occupational exposure level, if kept under 110 procedures per year. Excised prostate specimen radionuclide content was below the exemption level for Gallium-68. Dose rate based calculations provide a robust estimation for EPD measurements.

Keywords

ProstatectomyMedicineNuclear medicineHistopathologyDosimetryContext (archaeology)Prostate cancerCancerPathologyInternal medicine

Related papers

Browse all SURGICAL papers